IMM-20059
IMM-20059 is humanized IgG1 monoclonal antibody targeting EPN1. IMM-20059 in combination with Atezolizumab (HY-P9904) significantly enhances tumor regression in the B16.F10 syngeneic melanoma model compared to anti-PD-L1 monotherapy[1].
Product Specifications
UNSPSC
12352203
Target
Others
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
I[M][M20059]
References & Citations
[1]Fang Shen, et al. IMM20059, a novel anti-EPN1 antibody, in combination with atezolizumab significantly enhances tumor regression in the B16.F10 syngeneic melanoma model compared to anti-PD-L1 monotherapy. Immunome Poster at SITC Annual Meeting (November 8-12, 2022) .
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6267276-01 0.1 mL
Tau (Tau Protein, Microtubule-associated Protein, MAP) (BSA & Azide Free) (MaxLight 405)
Ask
View Details MBS6267276-02 5x 0.1 mL
Tau (Tau Protein, Microtubule-associated Protein, MAP) (BSA & Azide Free) (MaxLight 405)
Ask
View Details